Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
|
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis (RMS) | Greece | NCT06486779 | |
|
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Homozygous | Phase3 |
Austria China Germany Greece Malaysia Netherlands South Africa Taiwan Turkey (Türkiye) United Kingdom United States View all
|
NCT06597006 |
|
Pelacarsen Roll-over Extension Program |
Atherosclerotic Cardiovascular Disease | Phase3 | United States | NCT06875973 |
|
Ribociclib (LEE011) Rollover Study for Continued Access |
Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies | Phase2 |
Taiwan United States |
NCT02934568 |
|
Asciminib Roll-over Study |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase4 |
Argentina Austria Brazil Bulgaria Canada China Czechia France Germany Italy Malaysia Mexico Oman Poland Portugal Romania Russia South Korea Spain Turkey (Türkiye) United Kingdom United States Vietnam View all
|
NCT04877522 |
|
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines |
Chronic Spontaneous Urticaria (CSU) | Phase3 | United States | NCT06868212 |
|
Asciminib RMP Study |
Chronic Myeloid Leukemia | South Korea | NCT05943522 | |
|
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia |
Myeloid Leukemia, Philadelphia Positive | Phase1, Phase2 |
China France Germany Greece Hungary Italy Japan Netherlands Poland Russia South Korea Thailand Turkey (Türkiye) United States View all
|
NCT04925479 |
|
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy |
Primary IgA Nephropathy | Phase3 |
Brazil Colombia Mexico United States View all
|
NCT04557462 |
|
Home Reported Outcomes in C3G Study |
C3 Glomerulopathy | United States | NCT07029542 |